Cargando…
B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung Disease
Systemic sclerosis is a systemic, autoimmune disease that in many patients affects not only the skin, but also internal organs, mainly the lung. It is clear that internal organ (ie, lung) involvement determines the prognosis. Therefore, there is an unmet need to introduce novel and more effective tr...
Autores principales: | Bounia, Constantina A., Liossis, Stamatis-Nick C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092104/ https://www.ncbi.nlm.nih.gov/pubmed/35611107 http://dx.doi.org/10.31138/mjr.33.1.1 |
Ejemplares similares
-
Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion
por: Liossis, Stamatis-Nick C., et al.
Publicado: (2022) -
B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence
por: Daoussis, Dimitrios, et al.
Publicado: (2011) -
Biologic Treatments in Interstitial Lung Diseases
por: Karampitsakos, Theodoros, et al.
Publicado: (2019) -
Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
por: Bounia, Constantina A, et al.
Publicado: (2021) -
A 40-Year-Old Woman with Asymmetric Arthritis and Skin Lesions
por: Bounia, Konstantina A., et al.
Publicado: (2019)